자궁육종의 다중 복합 치료

참고문헌 (77)

1. "Pathology and genetics of tumours of the breast and female genital organs" (2003), IARC Press
2. "Corpus mesenchymal tumors", pp.961~979 (2000), Lippincott Williams and Wilkins
3. "Prognostic factors and treatment modalities in uterine sarcoma", 25, pp.256~260 (2002)
4. "Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic catcinomas", 12, pp.687~690 (2002)
5. "Carcinosarcomas of the female genital tract a pathologic study of 29 metastatic tumors further evidence for the dominant role of the epithelial component and the conversion theory of histofenesis", 19, pp.664~674 (1995)
6. "The significance of epithelial differentiation in mixed mesodermal tumors of the uterus:a clinicopathologic and immunohistochemical study", 14, pp.317~28 (1990)
7. "Treatment of uterine leiomyosarcoma", 71, pp.845~50 (1988)
8. "Management of uterine leiomyosarcoma in Australia", 39, pp.93~98 (1999)
9. "Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus", 91, pp.209~212 (2003)
10. "Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy", 89, pp.460~469 (2003)
11. "Regression of uterine low-grade smooth muscle tumors metastatic to the lung after oophorectomy", 89, pp.850~852 (1997)
12. "Prognostic factors in early-stage uterine sarcoma:A Gynecologic Oncology Group study", 71, pp.1702~9 (1993)
13. "Uterine leiomyosarcoma and endometrial stromal sarcoma:Lymph node metastasis and sites of recurrence", 50, pp.105~9 (1993)
14. "Primary treatment of uterine sarcomas" (2000)
15. "Adenosarcoma of the uterus:A Gynecologic Oncology Group clinicopathologic study of 31 cases", 11, pp.75~88 (1992)
16. "Cluster of uterine mullerian adenosarcoma in the Washington DC metropolitan area with high incidence of sarcomatous overgrowth", 23, pp.809~814 (1999)
17. "Uterine sarcoma:An analysis of 74 cases", 156, pp.370~4 (1987)
18. "A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus:a Gynecologic Oncology Group study", 79, pp.147~153 (2000)
19. "Treatment of recurrent or advanced uterine sarcoma A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide a phase III trial of the Gynecologic Oncology Group", pp.1648~53
20. "A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas", 52, pp.626~32 (1983)
21. "Treatment of advanced uterine sarcoma with adryamicin", 16, pp.101~4 (1983)
22. "Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus:a gynecologic oncology group study", 166, pp.556~9 (1992)
23. "Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study", 23, pp.355~357 (2000)
24. "Phase II trial of paclitaxel in leiomyosarcoma of the uterus:a Gynecologic Oncology Group study", 74, pp.346~349 (1999)
25. "Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas:a Gynecologic Oncology Group study", 9, pp.1962~6 (1991)
26. "Phase II trial of etoposide in leiomyosarcoma of the uterus:a Gynecologic Oncology Group study", 63, pp.120~122 (1996)
27. "Phase II study of mitomycin and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group study", 85, pp.507~510 (2002)
28. "Combination chemotherapy with hydroxyurea, dacarbazine (DTIC) and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study", 61, pp.27~30 (1996)
29. "Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus:a Gynecologic Oncology Group study", 62, pp.226~229 (1996)
30. "Amonafide in patients with leiomyosarcoma of the uterus:a phase II Gynecologic Oncology Group study", 21, pp.145~146 (1998)
31. "Aminothiadiazole in the treatment of advanced leiomyosarcoma of the uterine corpus. A Gynecologic Oncology Group study", 18, pp.397~399 (1995)
32. "Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus:a gynecologic oncology group study", 70, pp.267~271 (1998)
33. "A phase II clinical trial of diaziquone in the treatment of patients with recurrent leiomyosarcoma of the uterus", pp.207~8
34. "Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus:a Gynecologic Oncology Group study", 89, pp.48~51 (2003)
35. "Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) study", 92, pp.644~647 (2004)
36. "Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus:a phase II study of the Gynecologic Oncology Group", 84, pp.140~144 (2002)
37. "Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma:results of a phase II trial", 12, pp.2824~2831 (2002)
38. "Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus:a Gynecologic Oncology Group study", 161, pp.309~12 (1989)
39. "Phase II trial of hydroxyurea in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study", 61, pp.94~96 (1996)
40. "Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group", 39, pp.481~487 (2003)
41. "A phase II trial of amonafide in patients with mixed mesodermal tumors of the uterus:a Gynecologic Oncology Group study", 21, pp.306~307 (1998)
42. "A phase II trial of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus:a Gynecologic Oncology Group study", 19, pp.400~402 (1996)
43. "Paclitaxel in the treatment of carcinosarcoma of the uterus:a Gynecologic Oncology Group study", 83, pp.268~270 (2001)
44. "A phase II trial of diaziquone in mixed mesodermal sarcomas of the uterus", pp.93~4
45. "Phase II evaluation of oral trimetrexate in mixed mesodermal tumors of the uterus:a Gynecologic Oncology Group study", 85, pp.311~314 (2002)
46. "Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus", 94, pp.774~778 (2004)
47. "Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy:a study of the Gynecologic Oncology Group", 87, pp.747~750 (1996)
48. "Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel", 11, pp.275~278 (2000)
49. "Patterns of metastasis in uterine sarcoma", pp.935~8
50. "Prophylactic chemotherapy in stage I and II uterine sarcoma", 8, pp.346~8 (1979)
51. "Impact on pregression-free survival of adjuvant cyclophosphamide chemotherapy for stage I uterine sarcoma", 18, pp.282~286 (1995)
52. "A randomized clinical trial of adjuvant adriamycin in uterine sarcomas:a Gynecologic Oncology Group Study", 3, pp.1240~5 (1985)
53. "Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma", 78, pp.221~227 (2000)
54. "Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas:results of long-term follow-up", 14, pp.659~664 (2004)
55. "Uterine sarcomas:Analysis of failures with special emphasis on the use of adjuvant radiation therapy", 42, pp.1161~70 (1978)
56. "Radiotherapy and", or chemotherapy as adjuvant treatment of uterine sarcomas, 1985, pp.20, 281~9
57. "Uterine sarcomas:Prognostic factors and treatment modalities-Study on 209 patients", 24, pp.58~67 (1986)
58. "Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma", 12, pp.2127~30 (1986)
59. "Uterine sarcomas:A review of the Edinburgh experience from 1974 to 1992", 66, pp.998~1001 (1993)
60. "Impact of radiotherapy on local control and survival in uterine sarcomas:A retrospective study from the Group Oncologic Catala- Occita", 44, pp.47~52 (1999)
61. "Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri", 83, pp.1972~1979 (1998)
62. "Clinicopathologic analysis of uterine malignant mixed mullerian tumors", 34, pp.372~78 (1989)
63. "The role of whole pelvic irradiation in the treatment of early-stage uterine carcinosarcoma", 65, pp.493~498 (1997)
64. "The impact of adjuvant radiotherapy on carcinosarcoma of the uterus", 68, pp.8~13 (1998)
65. "Multimodality therapy for patients with clinical stage I and II malignant mixed mullerian tumors of the uterus", 91, pp.1437~1443 (2001)
66. "Uterine leiomyosarcoma:Anlaysis of treatment failures and survival", 62, pp.25~32 (1996)
67. "Endolymphatic stromal myosis:surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy", 50, pp.1888~93 (1982)
68. "Endometrial stromal sarcoma:objective response to letrozole", 82, pp.384~388 (2001)
69. "Long term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma", 20, pp.87~93 (2003)
70. "Low- grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole:case report", 95, pp.769~771 (2004)
71. "Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas", 38, pp.233~9 (1988)
72. "and cyclophosphamide therapy in stage I uterine sarcomas", dacti(mycin), pp.1451~4, Adjuvant vincristine
73. "Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study", 96, pp.630~634 (2005)
74. "Effect of adjuvant chemotherapy on long-term survival of stage I uterine sarcoma", 18 (1999)
75. "A phase II study of etoposide and doxorubicin chemotherapy in mixed mullerian tumors of the uterus", 56, pp.370~375 (1995)
76. "Long-term survival with metastatic uterine sarcoma", 85, pp.195~6 (1985)
77. "Sarcoma of the uterus:A clinical study of 42 patients", 258, pp.171~180 (1996)

관련 논문AI추천